EUVIMEDEUVIMED entdecken
Crossref

No difference in survival for primary cutaneous Merkel cell carcinoma after Mohs micrographic surgery and wide local excision

Kevin J Moore, Manisha Thakuria, Emily S Ruiz

Journal of the American Academy of Dermatology · 2023

DOI: 10.1016/j.jaad.2023.04.042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2023. Verfasst von Kevin J Moore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Skin Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The preferred treatment for clinically node-negative Merkel cell carcinoma (MCC) is surgical excision in conjunction with sentinel lymph node biopsy. There is limited large-scale research on survival outcomes by surgical approach for management of the primary tumor. OBJECTIVE: To compare overall and MCC-specific survival outcomes in clinically and pathologically, node-negative MCC patients treated with wide-local excision (WLE) and Mohs micrographic surgery (MMS) in a nationally representative sample. METHODS: Overall and MCC-specific survival outcomes for primary MCC tumors contained in the SEER (Surveillance, Epidemiology, and End Results)-18 database from 1989 to 2015 were stratified by surgical modality and analyzed via competing risk analysis. RESULTS: A total of 2359 US adults with MCC were included in the analysis. For overall and MCC-specific survival, there was no significant difference in survival outcomes between WLE and MMS on multivariable analysis (hazard ratio, 1.04 [95% CI, 0.88-1.22]; subdistribution hazard ratio, 0.76 [95% CI, 0.53-1.09]). Sentinel lymph node biopsy was associated with improved overall survival and MCC-specific survival. LIMITATIONS: Retrospective design of SEER and the lack of covariates such as comorbidities and immunostaining. CONCLUSION: There is no survival disadvantage for MMS compared to WLE as the surgical modality for primary cutaneous MCC. Sentinel lymph node biopsy should be coordinated prior to MMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Merkel CellSkin NeoplasmsAdultHumansMohs SurgeryRetrospective StudiesProportional Hazards ModelsNeoplasm Recurrence, Local

Stichwörter der Autor:innen

Merkel cell carcinomaMohs micrographic surgerycompeting risk analysissurgical outcomessurvival analysiswide local excision

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Dana Farber/Brigham and Women's Cancer Center, Boston, Massachuse…

Zitieren

APA

Moore, K. J., Thakuria, M., & Ruiz, E. S. (2023). No difference in survival for primary cutaneous Merkel cell carcinoma after Mohs micrographic surgery and wide local excision. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2023.04.042

Vancouver

Moore KJ, Thakuria M, Ruiz ES. No difference in survival for primary cutaneous Merkel cell carcinoma after Mohs micrographic surgery and wide local excision. Journal of the American Academy of Dermatology. 2023. doi:10.1016/j.jaad.2023.04.042

BibTeX
@article{Moore2023,
  author = {Moore, Kevin J and Thakuria, Manisha and Ruiz, Emily S},
  title = {No difference in survival for primary cutaneous Merkel cell carcinoma after Mohs micrographic surgery and wide local excision},
  journal = {Journal of the American Academy of Dermatology},
  year = {2023},
  doi = {10.1016/j.jaad.2023.04.042}
}
Kostenlos starten →